Old Web
English
Sign In
Acemap
>
authorDetail
>
G. Pagano
G. Pagano
Hoffmann-La Roche
Internal medicine
Parkinson's disease
Medicine
Population study
Sample size determination
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design and baseline data
2021
medRxiv
G. Pagano
F.G. Boess
K. I. Taylor
B Ricci
Brit Mollenhauer
Werner Poewe
A. Boulay
J. Anzures-Cabrera
A. Vogt
M. Marchesi
A. Post
T. Nikolcheva
G G Kinney
W Zago
D. K. Ness
H. Svoboda
M. Britschgi
S Ostrowitzki
Tanya Simuni
Kenneth Marek
M. Köller
J. Sevigny
R. Doody
P. Fontoura
D. Umbricht
A. Bonni
Show All
Source
Cite
Save
Citations (2)
Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [11C]-PHNO PET study.
2021
Parkinsonism & Related Disorders
G. Pagano
S Molloy
Peter G. Bain
Eugenii A. Rabiner
K. Ray Chaudhuri
David J. Brooks
Nicola Pavese
Show All
Source
Cite
Save
Citations (1)
1